GABA concentration:
Aim: Apply different concentrations of GABA to activate GABAA receptors
In our experiments, we investigate GABAA receptors. We measure chloride ion (Cl−) currents across the neuronal membrane in response to GABA application. By applying GABA or pharmacological modulators, we can analyze the receptor's activation, desensitization, and inhibition kinetics. These measurements help us understand how GABAA receptors mediate fast synaptic inhibition and how various compounds, such as benzodiazepines, muscimol, or bicuculline, influence receptor function.
µM
Aim: Apply different BDZ concentration.
To evaluate how different drug concentrations affect the GABAA receptor, we construct dose-response curves by measuring the extent of current modulation at each concentration. Cells expressing GABAA receptors are exposed to increasing doses of a test compound in the presence of GABA. The percent potentiation is plotted against the logarithm of the drug concentration. By fitting the data with a standard Hill equation, we can determine key pharmacological parameters such as the half-maximal effective concentration (EC50) and the Hill coefficient, which provide insight into the potency and cooperativity of the drug-receptor interaction.
Apply different drug's concentrations
GABA concentration:
µM
BDZ concentration (0.001-100):
µM
GABAA Receptors: Structure and Function
GABAA receptors are ligand-gated ion channels that mediate fast synaptic inhibition in the central nervous system. When activated by GABA (γ-aminobutyric acid), they allow chloride ions to enter the neuron, leading to hyperpolarization and reduced excitability.
Structure and Subunits
These receptors are pentameric, made up of five subunits selected from a family of 19 types: α(1–6), β(1–3), γ(1–3), δ, ε, π, ρ(1–3), and θ. The subunit combination determines the receptor's pharmacology and GABA sensitivity.
Drug Binding Sites
GABA binds at the α–β interface, while benzodiazepines bind at the α–γ2 interface. Some compounds, like picrotoxin, block the chloride channel directly. These sites are key targets for sedatives, anticonvulsants, and anesthetics.
Key Ligands and Effects
Common modulators include:
- Muscimol – GABA agonist from mushrooms, induces strong inhibition.
- Bicuculline – Antagonist that blocks GABA, promoting excitability.
- Picrotoxin – Convulsant that blocks the Cl− channel.
- Benzodiazepines – Enhance GABA effects via allosteric modulation.
Clinical Relevance
GABAA receptors are essential for controlling brain activity. Their modulation is the basis for many treatments against anxiety, epilepsy, and insomnia.